New data from several vaccine trials offer positive signs, but many public health experts say emerging variants mean the next few months will be a race against the virus.
Tag: Pfizer Inc
Top E.U. Official Comes Under Fire in Vaccine Wars
Ursula von der Leyen has largely stayed away from the limelight while driving the handling of a crisis and letting subordinates take the blame.
Top E.U. Official Comes Under Fire in Vaccine Wars
Ursula von der Leyen has largely stayed away from the limelight while driving the handling of a crisis and letting subordinates take the blame.
Pregnant Women Get Conflicting Advice on Covid-19 Vaccines
The W.H.O. and the C.D.C. provide differing views, and experts partly blame a lack of data because expectant mothers have been excluded from clinical trials.
Governments Sign Secret Vaccine Deals. Here’s What They Hide.
Multibillion-dollar contracts give drug makers liability shields, patent ownership and leeway on delivery dates and pricing — and promises that much of it will not be made public.
E.U. and U.K. Fight Over Covid Vaccines: ‘Solidarity Is Failing’
As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.
‘Solidarity Is Failing’: E.U. and U.K. Fight Over Scarce Vaccines
As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.
In Israel, Infections Drop Sharply After One Shot of Vaccine
Initial studies show a significant drop in infections and hospitalizations after just one dose, and very few cases after two. Experts caution that the results are preliminary.
China Wanted to Show Off Its Vaccines. It’s Backfiring.
Delays, inconsistent data, spotty disclosures and the country’s attacks on Western rivals have marred its ambitious effort to portray itself as a leader in global health.
Emerging Coronavirus Variants May Pose Challenges to Vaccines
Laboratory studies of mutations circulating in South Africa suggest they may dodge some of the body’s immune responses.